A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

NCT02770378 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Aprepitant
DRUG: Minocycline
DRUG: Disulfiram
DRUG: Celecoxib
DRUG: Sertraline
DRUG: Captopril
DRUG: Itraconazole
DRUG: Ritonavir
DRUG: Auranofin

Sponsor

University of Ulm

Collaborators

[object Object]
[object Object]